Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
36,811,567
-
Shares change
-
+4,957,973
-
Total reported value, excl. options
-
$730,751,052
-
Value change
-
+$98,792,888
-
Put/Call ratio
-
19%
-
Number of buys
-
64
-
Number of sells
-
-32
-
Price
-
$19.85
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2017
122 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2017.
NovoCure Ltd - Common Stock (NVCR) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,811,567 shares
of 111,111,111 outstanding shares and own 33.13% of the company stock.
Largest 10 shareholders include FMR LLC (7,796,935 shares), GOLDMAN SACHS GROUP INC (4,887,452 shares), VANGUARD GROUP INC (4,478,442 shares), BlackRock Inc. (3,926,454 shares), StepStone Group LP (1,615,479 shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1,514,010 shares), STATE STREET CORP (1,079,228 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (833,576 shares), PointState Capital LP (752,900 shares), and RHENMAN & PARTNERS ASSET MANAGEMENT AB (666,528 shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.